Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracameral Moxifloxacin for Endophthalmitis Prophylaxis
NCT05079854Phase 4Unknown
- Sponsor
- Federal University of São Paulo
- Start
- Oct 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Moxisurge in endophthalmitis, sponsored by Federal University of São Paulo. Status: unknown.
02
Drugs
Moxisurge
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT05079854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05079854.